TNFAIP3 and rheumatoid arthritis: Studies utilizing bone marrow-specific A20 (TNFAIP3) knockout mice have demonstrated that targeted deletion of TNFAIP3 in hematopoietic cells leads to spontaneous development of severe, destructive polyarthritis, closely resembling the clinical and pathological features of RA.